Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 20/20 | 0.55 |
| ▸ | PPARD | Q03181 | 15/20 | 0.55 |
| ▸ | PPARG | P37231 | 14/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30007652 | 0.87 | PPARD (0.56) | PPARAPPARDPPARG | |
| SCHEMBL2030587 | 0.87 | PPARA (0.51) | PPARAPPARDPPARG | |
| SCHEMBL3513353 | 0.86 | PPARD (0.57) | PPARAPPARDPPARG | |
| SCHEMBL21017562 | 0.78 | PPARA (0.52) | PPARAPPARDPPARGCYP1A2CYP2C9 | |
| SCHEMBL21017736 | 0.78 | PPARA (0.52) | PPARAPPARDPPARGCYP1A2CYP2C9 | |
| SCHEMBL21016849 | 0.78 | PPARA (0.52) | PPARAPPARDPPARGCYP1A2CYP2C9 | |
| SCHEMBL16472647 | 0.78 | PPARA (0.45) | PPARAPPARDPPARG | |
| SCHEMBL1934554 | 0.77 | PPARA (0.58) | PPARAPPARDPPARGCYP1A2CYP2C9 | |
| SCHEMBL30007594 | 0.77 | PPARD (0.47) | PPARAPPARDPPARG | |
| SCHEMBL2029585 | 0.77 | PPARA (0.49) | PPARAPPARDPPARGCYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4337184-A1 | PPAR-AGONISTS FOR USE IN THE TREATMENT OF LIVER FAILURE | Genfit (FR) | 2024-03-20 | — | — | EP | disclosed |
| EP-4337185-A1 | ELAFIBRANOR DERIVATIVES AGONISTS OF PPAR FOR USE IN THE TREATMENT OF SEPSIS | Genfit (FR) | 2024-03-20 | — | — | EP | disclosed |
| WO-2022238445-A1 | PPAR-AGONISTS FOR USE IN THE TREATMENT OF LIVER FAILURE | GENFIT (FR) | 2022-11-17 | — | — | WO | disclosed |
| WO-2022238448-A1 | ELAFIBRANOR DERIVATIVES AGONISTS OF PPAR FOR USE IN THE TREATMENT OF SEPSIS | GENFIT (FR) | 2022-11-17 | — | — | WO | disclosed |